AFG3L1P |
|
AFG3 like matrix AAA peptidase subunit 1, pseudogene
|
|
|
0.931 |
0.115 |
ETF1P1 |
|
eukaryotic translation termination factor 1 pseudogene 1
|
|
|
1.000 |
0.115 |
LINC01416 |
|
long intergenic non-protein coding RNA 1416
|
|
|
0.890 |
0.154 |
LINC02143 |
|
long intergenic non-protein coding RNA 2143
|
|
|
0.890 |
0.154 |
LINC01496 |
|
long intergenic non-protein coding RNA 1496
|
|
|
0.890 |
0.154 |
COLCA2 |
A8K830
|
colorectal cancer associated 2
|
|
0.75 |
0.769 |
0.154 |
COLCA1 |
Q6ZS62
|
colorectal cancer associated 1
|
|
|
0.780 |
0.154 |
MAP1LC3B2 |
A6NCE7
|
microtubule associated protein 1 light chain 3 beta 2
|
|
1.3E-02 |
0.931 |
0.192 |
ZNF230 |
Q9UIE0
|
zinc finger protein 230
|
|
8.3E-02 |
0.931 |
0.192 |
RHPN2 |
Q8IUC4
|
rhophilin Rho GTPase binding protein 2
|
Enzyme modulator
|
1.1E-07 |
0.711 |
0.192 |
PTCSC2 |
|
papillary thyroid carcinoma susceptibility candidate 2
|
|
|
0.751 |
0.231 |
EHBP1 |
Q8NDI1
|
EH domain binding protein 1
|
|
0.31 |
0.839 |
0.231 |
PADI6 |
Q6TGC4
|
peptidyl arginine deiminase 6
|
|
|
0.760 |
0.269 |
EMBP1 |
|
embigin pseudogene 1
|
|
|
0.839 |
0.269 |
CASC16 |
|
cancer susceptibility 16
|
|
|
0.780 |
0.308 |
HYKK |
A2RU49
|
hydroxylysine kinase
|
|
7.3E-06 |
0.769 |
0.346 |
POU5F1B |
Q06416
|
POU class 5 homeobox 1B
|
|
2.9E-04 |
0.670 |
0.346 |
RTEL1-TNFRSF6B |
|
RTEL1-TNFRSF6B readthrough (NMD candidate)
|
|
|
0.682 |
0.385 |
GRAMD1B |
Q3KR37
|
GRAM domain containing 1B
|
|
1.00 |
0.736 |
0.385 |
EEFSEC |
P57772
|
eukaryotic elongation factor, selenocysteine-tRNA specific
|
Enzyme
|
2.7E-08 |
0.751 |
0.385 |
PRNCR1 |
|
prostate cancer associated non-coding RNA 1
|
|
|
0.722 |
0.385 |
DRAIC |
|
downregulated RNA in cancer, inhibitor of cell invasion and migration
|
|
|
0.736 |
0.423 |
PHLDB1 |
Q86UU1
|
pleckstrin homology like domain family B member 1
|
|
0.11 |
0.722 |
0.423 |
CASC19 |
|
cancer susceptibility 19
|
|
|
0.769 |
0.423 |
OSGIN1 |
Q9UJX0
|
oxidative stress induced growth inhibitor 1
|
|
1.6E-11 |
0.729 |
0.423 |